DanielPCahillMDPhD

Brain & Spinal Tumor

Associate Professor, Neurosurgery-Massachusetts General Hospital, Harvard Medical School

Dr. Cahill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
55 Fruit St
Massachusetts General Hospital Nsurg HST
Boston, MA 02114
Phone+1 617-726-2066

Fax+1 617-726-4814

Dr. Daniel Cahill is a neurosurgeon in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 16 years. He specializes in brain & spinal tumor and is experienced in neurosurgical oncology, including primary brain tumors (IDH mutant glioma, astrocytoma, oligodendroglioma, and glioblastoma), metastatic brain tumors (including melanoma, lung cancer, breast cancer), and meningioma.

PubMed

Thrombosis, brain metastasis formation, and the perivascular metastatic niche-Novel insights from the tumor microvascular circulation.
Christopher Alvarez-Breckenridge, Priscilla K Brastianos, Daniel P Cahill
Neuro-Oncology. 2024-11-04
Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma.
Eric P Grewal, Leland G K Richardson, Jing Sun, Rishab Ramapriyan, Maria Martinez-Lage
Clinical Cancer Research. 2024-09-13
3 citations
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma.
Mihir Gupta, Joseph D Bradley, Elie Massaad, Evan J Burns, N Zeke Georgantas
Blood. 2024-09-05

Journal Articles

The Dual PI3K/mTOR-pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA-Mutant Breast Cancer Brain Metastases
Priscilla K Brastianos, Daniel P Cahill, Clinical Cancer Research
DMD Genomic Deletions Characterize a Subset of progressive/higher-grade Meningiomas with Poor Outcome
Ganesh M Shankar, Sandro Santagata, Priscilla K Brastianos, Daniel P Cahill, Acta Neuropathologica
Cell Surface Notch Ligand DLL3 Is a Therapeutic Target in Isocitrate Dehydrogenase Mutant Glioma
John G Golfinos, Daniel P Cahill, Erik P Sulman, David Zagzag, Clinical Cancer Research

New Targeted Glioma Therapy Could Suppress Tumor GrowthAugust 9th, 2018
Rapid Diagnostic Coupled with Local Therapy Developed for Brain TumorsAugust 6th, 2018
Molecular Approach to Brain Tumors Improves TreatmentFebruary 10th, 2016